...
首页> 外文期刊>Allergy >Asthma is associated with reduced fibrinolytic activity, abnormal clot architecture, and decreased clot retraction rate
【24h】

Asthma is associated with reduced fibrinolytic activity, abnormal clot architecture, and decreased clot retraction rate

机译:

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to assess whether steroid-naive asthma modulates hemostasis. We evaluated the clot retraction rate (CRR), fibrinolysis rate (FR), clot density (CD) (by confocal microscopy), plasma levels of plasminogen activator inhibitor (PAI-1), and factor XIII (FXIII), NO in exhaled breath (FENO), spirometry (FEV1) and eosinophil count (EOS) in 36 patients with allergic, steroid-nave asthma and in 34 healthy controls. We observed significantly (P < 0.001) reduced CRR, FR, and FEV1 and increased FENO, EOS, PAI-1, FXIII, and CD in patients with asthma compared with controls. In patients with asthma, FR negatively correlated with CD, FXIII, PAI-1, FEN, and EOS and positively with FEV1. FXIII positively correlated with CD. Clot retraction rate negatively correlated with FEND and positively with FEV1 (all P < 0.001). These novel findings suggest that asthma itself is associated with decreased CRR and reduced fibrinolytic potential resulting from alterations in clot architecture and elevated levels of plasma FXIII and PAI-1.

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号